The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of lurbinectedin as second-line therapy in Chinese patients with small cell lung cancer: Preliminary results of a phase 1 study.
 
Ying Cheng
No Relationships to Disclose
 
Chunjiao Wu
No Relationships to Disclose
 
Lulu Chen
No Relationships to Disclose
 
Ying Xin
No Relationships to Disclose
 
Liang Zhang
No Relationships to Disclose
 
Pinghua PAN
No Relationships to Disclose
 
Lin Wu
Employment - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Hengrui Pharmaceutical ; Innovent Biologics; Lilly; Merck; MSD; Pfizer; Roche
 
Juan Li
No Relationships to Disclose
 
Yanqiu Zhao
No Relationships to Disclose
 
Xingya Li
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Xiaorong Dong
No Relationships to Disclose